Meeting to be held in Chicago on January 23 and in the Midwest on January 24 hosted by Piper Sandler.Invest with Confidence: Follow TipRanks' ...

Chicago, IL – January 24, 2025 – Today, Zacks Equity Research Equity are Enovis ENOV, Omnicell OMCL and Phreesia PHR. Link: ...

RBC Capital analyst Sean Dodge upgraded Phreesia (PHR) to Outperform from Sector Perform with a price target of $32, up from $24. The firm ...

Analyst predicts Phreesia's revenue per client will accelerate, as company shifts focus to monetizing existing clients. Upgraded rating and PT raised.

Phreesia (PHR) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $31.0, a high estimate of $34.00, and a low estimate of $29.00. This upward trend is apparent, ...

Phreesia (PHR) closed the last trading session at $23.84, gaining 25.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall ...

Phreesia, Inc. engages in the provision of patient check-in solutions for medical practices. The firm offers appointments, clinical support, integration, registration, patient activation ...

Phreesia, Inc. (NYSE:PHR – Get Free Report) has earned a consensus rating of “Buy” from the twelve brokerages that are covering the company, MarketBeat.com reports. Twelve analysts have rated the ...

Phreesia (NYSE:PHR – Free Report) had its price objective raised by Citigroup from $31.00 to $35.00 in a research note issued to investors on Friday morning,Benzinga reports. They currently have a buy ...

January 17, 2025, 04:12 am ET, BY Momei- Contributor, Stock Traders Daily| Editor: Thomas H. Kee Jr. ( Follow on LinkedIn) ...